TrialFrontiers in immunology2022

Safety and immunogenicity of BK-SE36 in a blinded, randomized, controlled, age de-escalating phase Ib clinical trial in Burkinabe children.

Edith Christiane Bougouma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.